PA
HWC icon

PharVision Advisers’s Hancock Whitney HWC Stock Holding History

PharVision Advisers’s Portfolio HWC Stock Details HWC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,082
Closed -$424K – 349
2025
Q1 		$424K Buy
+8,082
New +$455K 0.59% 25

Other funds holding HWC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

PharVision Advisers's HWC Position: Q2 2025 in Review

PharVision Advisers sold out of Hancock Whitney (HWC) in Q2 2025, closing a stake of 8,082 shares — an estimated $424K sold.

PharVision Advisers first reported a position in HWC in Q1 2025 and held it in 1 quarter. The position peaked at $424K in Q1 2025. 357 funds tracked by Wall St. Rank hold HWC as of Q2 2025.

  • PharVision Advisers reported no remaining Hancock Whitney position as of Q2 2025 after selling out during the quarter.
  • PharVision Advisers sold 8,082 Hancock Whitney shares in Q2 2025, an estimated $424K.
  • PharVision Advisers first reported a position in Hancock Whitney in Q1 2025 and held it in 1 quarter.
  • PharVision Advisers's Hancock Whitney position peaked at $424K in Q1 2025.
  • 357 funds tracked by Wall St. Rank held Hancock Whitney as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.